Canreal Injection 1's

Canreal Injection 1's belongs to the group of medicines called 'antiplatelet agents' used to prevent the formation of blood clots, thereby reducing the chance of Myocardial infarction. Canreal Injection 1's is used during percutaneous coronary intervention (PCI) procedure to reduce the chance of blood clot formation.

Canreal Injection 1's contains Cangrelor, which works by inhibiting the clumping of platelets, thereby reducing the chance of blood clot formation. This results in lower cardiovascular events like myocardial infarction (heart attack), repeat coronary revascularization, and stent thrombosis (ST).

Canreal Injection 1's will be administered by your doctor. So, do not self-administer. The dose of the medicine will be decided by your doctor based on your health condition. Canreal Injection 1's may cause certain side effects such as nose bleeds, skin rash, bleeding in the bowels, blood in urine, low haemoglobin, indigestion and bruising. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor.

Canreal Injection 1's should not be used if you ever had a brain stroke, bleeding in the brain or transient ischemic attack (stroke). Talk to your doctor before receiving Canreal Injection 1's, have/had a recent severe injury or surgery due to risk of severe bleeding problems. If you are pregnant or breastfeeding, inform your doctor before receiving this medicine. Canreal Injection 1's is not recommended for children as efficacy and safety have not been established.

Canreal Injection 1's belongs to the group of medicines called antiplatelet agents (P2Y12 platelet inhibitors) used to prevent the formation of blood clots. Canreal Injection 1's helps in reducing the chance of having a myocardial infarction (heart attack), repeat coronary revascularization, and stent thrombosis (ST). Canreal Injection 1's works by inhibiting the clumping of platelets, thereby reducing the chance of blood clot formation. This helps in reducing the rate of cardiovascular events such as myocardial infarction (heart attack) or stroke, especially in people who have had heart surgery, known as angioplasty.

• Nose bleeds
• Skin rash
• Bleeding in bowels
• Blood in urine
• Indigestion
• Bruising

Do not receive Canreal Injection 1's if you are allergic to it or if you have a medical condition that causes bleeding from the stomach or intestine, had a transient ischemic attack (stroke) or if you are suffering from severe liver disease. Let your doctor know if you have bleeding problems, had/have a recent serious injury or surgery, or kidney or liver disease before receiving this medicine. Consult your doctor immediately if you develop a medical condition called thrombotic thrombocytopenic purpura (blood disorder) while on treatment with Canreal Injection 1's. Pregnant or breastfeeding mothers should inform their doctor before receiving this medicine. Canreal Injection 1's is not recommended for children as efficacy and safety have not been established. People affected with active pathological bleeding (peptic ulcer, intracranial or brain haemorrhage) and a history of stroke or transient ischemic attack (TIA) should not take Canreal Injection 1's.

• ASPIRIN
• IBUPROFEN
• CELECOXIB
• CLOPIDOGREL
• ENOXAPARIN
• TICAGRELOR
• PRASUGREL
• RIVAROXABAN

• Eat a diet rich in whole grains, vegetables, fruits, skinless poultry, fish, eggs, and low-fat dairy products.
• Avoid smoking and alcohol consumption.
• Maintain a healthy weight with proper diet and exercise.
• Managing stress with meditation, yoga, and massage.
• Avoid eating fried food, fast food, boxed food, canned food, and processed frozen meals.